PD L1 News and Research

RSS
Blood-based biomarker can predict the benefit of immunotherapy to lung cancer patients

Blood-based biomarker can predict the benefit of immunotherapy to lung cancer patients

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Immunotherapy combined with chemoradiation and surgery could help treat nonmetastatic gastroesophageal cancer

Immunotherapy combined with chemoradiation and surgery could help treat nonmetastatic gastroesophageal cancer

Immunotherapy after bladder cancer surgery helps reduce cancer recurrence

Immunotherapy after bladder cancer surgery helps reduce cancer recurrence

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

New bioinformatics platform predicts optimal treatment combinations for cancer patients

New bioinformatics platform predicts optimal treatment combinations for cancer patients

Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

Study finds better immunotherapy response in lung cancer patients with genetic variant linked to autoimmune disease

NSCLC patients treated with KRAS G12C inhibitor sotorasib may receive long-term clinical benefit

NSCLC patients treated with KRAS G12C inhibitor sotorasib may receive long-term clinical benefit

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

Combination immunotherapy reverses resistance to PD-1 inhibitors in patients with advanced melanoma

City of Hope's late-breaking clinical trial data to be presented at AACR

City of Hope's late-breaking clinical trial data to be presented at AACR

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Natural compound found in cardamom shows promise for treating triple-negative breast cancer

Biological timeline of COVID-19 immune recovery described in new research

Biological timeline of COVID-19 immune recovery described in new research

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Biomarkers to identify SARS-CoV-2 patients requiring invasive mechanical ventilation

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Severity-dependent immune mechanisms in the cerebrospinal fluid and plasma of COVID-19 patients

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Combined strategy suppresses the growth of deadly brain tumor

Combined strategy suppresses the growth of deadly brain tumor